Skip to main content
Top
Published in: Gut Pathogens 1/2017

Open Access 01-12-2017 | Commentary

Bacteriophages in the gastrointestinal tract and their implications

Authors: Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska, Ewa Jończyk-Matysiak, Renata Wojciechowska, Andrzej Górski

Published in: Gut Pathogens | Issue 1/2017

Login to get access

Abstract

The gut microbiota plays an essential role in health and disease of humans. Bacteriophages are the most abundant members of the gut virobiota and display great diversity. Phages can translocate through the mucosa to lymph and internal organs and play a role as regulators of the bacterial population in the gut. Increasing abundance of phages in the gut mucosa may reduce colonization by bacteria. Moreover, phages may have an immunomodulatory role in the immune response in the human gut. The role of phages in inflammatory bowel disease (IBD) remains unknown. Phages may take part in the development of IBD, but there are also data suggesting the protective role of phages in the gut of patients with IBD. Furthermore, recent data suggest that phages may mediate the beneficial effects of fecal microbiota transplantation (FMT). Therefore, evidence is accumulating to highlight the protective immunomodulating activity of the gut phages.
Literature
1.
go back to reference Abeles SR, Pride DT. Molecular bases and role of viruses in the human microbiome. J Mol Biol. 2014;426:3892–906.CrossRefPubMed Abeles SR, Pride DT. Molecular bases and role of viruses in the human microbiome. J Mol Biol. 2014;426:3892–906.CrossRefPubMed
2.
go back to reference Górski A, Weber-Dąbrowska B. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci. 2005;62:511–9.CrossRefPubMed Górski A, Weber-Dąbrowska B. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci. 2005;62:511–9.CrossRefPubMed
3.
go back to reference Kutter EM, Kuhl SJ, Abedon ST. Re-establishing a place for phage therapy in western medicine. Future Microbiol. 2015;10:685–8.CrossRefPubMed Kutter EM, Kuhl SJ, Abedon ST. Re-establishing a place for phage therapy in western medicine. Future Microbiol. 2015;10:685–8.CrossRefPubMed
4.
go back to reference Chanishvili N. Bacteriophages as therapeutic and prophylactic means: summary of the Soviet and post Soviet experiences. Curr Drug Deliv. 2016;13:309–23.CrossRefPubMed Chanishvili N. Bacteriophages as therapeutic and prophylactic means: summary of the Soviet and post Soviet experiences. Curr Drug Deliv. 2016;13:309–23.CrossRefPubMed
5.
go back to reference Górski A, Międzybrodzki R, Weber-Dąbrowska B, et al. Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases. Front Microbiol. 2016;7:Art. 1515.CrossRef Górski A, Międzybrodzki R, Weber-Dąbrowska B, et al. Phage therapy: combating infections with potential for evolving from merely a treatment for complications to targeting diseases. Front Microbiol. 2016;7:Art. 1515.CrossRef
6.
go back to reference Sharma S, Chatterjee S, Datta S, Prasad R, Dubey D, Prasad RK, Vairale MG. Bacteriophages and its applications: an overview. Folia Microbiol. 2017;62:17–55.CrossRef Sharma S, Chatterjee S, Datta S, Prasad R, Dubey D, Prasad RK, Vairale MG. Bacteriophages and its applications: an overview. Folia Microbiol. 2017;62:17–55.CrossRef
7.
go back to reference Adams MH. The infective process. In: Adams MH, editor. Bacteriophages. New York: Interscience; 1959. p. 13–25. Adams MH. The infective process. In: Adams MH, editor. Bacteriophages. New York: Interscience; 1959. p. 13–25.
8.
go back to reference Ackermann HW, Węgrzyn G. General characteristics of bacteriophages. In: Borysowski J, Międzybrodzki R, Górski A, editors. Phage therapy: current research and applications. Norfolk: Caister Academic Press; 2014. p. 3–22. Ackermann HW, Węgrzyn G. General characteristics of bacteriophages. In: Borysowski J, Międzybrodzki R, Górski A, editors. Phage therapy: current research and applications. Norfolk: Caister Academic Press; 2014. p. 3–22.
10.
go back to reference Reyes A, Semenkovich NP, Whiteson K, Rohwer F, Gordon JI. Going viral: next-generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol. 2012;10:607–17.CrossRefPubMedPubMedCentral Reyes A, Semenkovich NP, Whiteson K, Rohwer F, Gordon JI. Going viral: next-generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol. 2012;10:607–17.CrossRefPubMedPubMedCentral
12.
go back to reference Adams MH. Methods of study of bacterial viruses. In: Adams MH, editor. Bacteriophages. New York: Interscience; 1959. p. 443–522. Adams MH. Methods of study of bacterial viruses. In: Adams MH, editor. Bacteriophages. New York: Interscience; 1959. p. 443–522.
13.
go back to reference Muniesa M, Jofre J. Identifying and analyzing bacteriophages in human fecal samples: what could we discover? Future Microbiol. 2014;9:879–86.CrossRefPubMed Muniesa M, Jofre J. Identifying and analyzing bacteriophages in human fecal samples: what could we discover? Future Microbiol. 2014;9:879–86.CrossRefPubMed
14.
go back to reference Lim ES, Wang D, Holtz LR. The bacterial microbiome and virome milestones of infant development. Trends Microbiol. 2016;24:801–10.CrossRefPubMed Lim ES, Wang D, Holtz LR. The bacterial microbiome and virome milestones of infant development. Trends Microbiol. 2016;24:801–10.CrossRefPubMed
15.
16.
go back to reference Minot S, Sinha R, Chen J, et al. The human gut virome: inter-individual variation and dynamic response to diet. Genom Res. 2011;21:1616–25.CrossRef Minot S, Sinha R, Chen J, et al. The human gut virome: inter-individual variation and dynamic response to diet. Genom Res. 2011;21:1616–25.CrossRef
17.
go back to reference Pérez-Brocal V, Garcia-López R, Vázquez-Castellanos JF, Nos P, Beltrán B, Latorre A, Moya A. Study of the viral and microbial communities associated with Crohn`s disease: a metagenomics approach. Clin Transl Gastroenterol. 2013;4:e36.CrossRefPubMedPubMedCentral Pérez-Brocal V, Garcia-López R, Vázquez-Castellanos JF, Nos P, Beltrán B, Latorre A, Moya A. Study of the viral and microbial communities associated with Crohn`s disease: a metagenomics approach. Clin Transl Gastroenterol. 2013;4:e36.CrossRefPubMedPubMedCentral
18.
go back to reference Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220–30.CrossRefPubMedPubMedCentral Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220–30.CrossRefPubMedPubMedCentral
19.
go back to reference Breitbart M, Hewson I, Felts B, Mahaffy JM, Nulton J, Salamon P, Rohwer F. Metagenomic analysis of an uncultured viral community from human feces. J Bacteriol. 2003;185:6220–3.CrossRefPubMedPubMedCentral Breitbart M, Hewson I, Felts B, Mahaffy JM, Nulton J, Salamon P, Rohwer F. Metagenomic analysis of an uncultured viral community from human feces. J Bacteriol. 2003;185:6220–3.CrossRefPubMedPubMedCentral
20.
go back to reference Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, Rohwer F, Gordon JI. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature. 2010;466:334–8.CrossRefPubMedPubMedCentral Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, Rohwer F, Gordon JI. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature. 2010;466:334–8.CrossRefPubMedPubMedCentral
22.
go back to reference Mills S, Shanahan F, Stanton C, Hill C, Coffey A, Ross RP. Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes. 2013;4:4–16.CrossRefPubMedPubMedCentral Mills S, Shanahan F, Stanton C, Hill C, Coffey A, Ross RP. Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes. 2013;4:4–16.CrossRefPubMedPubMedCentral
23.
go back to reference Davies EV, Winstanley C, Fothergill JL, James CE. The role of temperate bacteriophages in bacterial infection. FEMS Microbiol Lett. 2016;363(5):fnw015.CrossRefPubMed Davies EV, Winstanley C, Fothergill JL, James CE. The role of temperate bacteriophages in bacterial infection. FEMS Microbiol Lett. 2016;363(5):fnw015.CrossRefPubMed
24.
go back to reference Fothergill JL, Mowat E, Walshaw MJ, Ledson MJ, James CE, Winstanley C. Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011;55:426–8.CrossRefPubMed Fothergill JL, Mowat E, Walshaw MJ, Ledson MJ, James CE, Winstanley C. Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011;55:426–8.CrossRefPubMed
26.
go back to reference Lucas López R, Grande Burgos MJ, Gálvez A, Pérez Pulido R. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. APMIS. 2017;125:3–10.CrossRefPubMed Lucas López R, Grande Burgos MJ, Gálvez A, Pérez Pulido R. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. APMIS. 2017;125:3–10.CrossRefPubMed
27.
go back to reference Dalmasso M, Hill C, Ross RP. Exploiting gut bacteriophages for human health. Trends Microbiol. 2014;22:399–405.CrossRefPubMed Dalmasso M, Hill C, Ross RP. Exploiting gut bacteriophages for human health. Trends Microbiol. 2014;22:399–405.CrossRefPubMed
28.
go back to reference Wagner J, Maksimovic J, Farries G, et al. Bacteriophages in gut samples from pediatric Crohn’s disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm Bowel Dis. 2013;19:1598–608.CrossRefPubMed Wagner J, Maksimovic J, Farries G, et al. Bacteriophages in gut samples from pediatric Crohn’s disease patients: metagenomic analysis using 454 pyrosequencing. Inflamm Bowel Dis. 2013;19:1598–608.CrossRefPubMed
29.
go back to reference Norman JM, Handley SA, Baldridge MT, et al. Disease–specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160:447–60.CrossRefPubMedPubMedCentral Norman JM, Handley SA, Baldridge MT, et al. Disease–specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160:447–60.CrossRefPubMedPubMedCentral
30.
go back to reference Łusiak-Szelachowska M, Annabhani A, Weber-Dąbrowska B, et al. Escherichia coli bacteriophages in human stool of patients with gastrointestinal tract diseases. Gastroenterol Polska. 2008;15:87–90. Łusiak-Szelachowska M, Annabhani A, Weber-Dąbrowska B, et al. Escherichia coli bacteriophages in human stool of patients with gastrointestinal tract diseases. Gastroenterol Polska. 2008;15:87–90.
31.
go back to reference Górski A, Ważna E, Weber-Dąbrowska B, Dąbrowska K, Świtała-Jeleń K, Międzybrodzki R. Bacteriophage translocation. FEMS Immunol Med Microbiol. 2006;46:313–9.CrossRefPubMed Górski A, Ważna E, Weber-Dąbrowska B, Dąbrowska K, Świtała-Jeleń K, Międzybrodzki R. Bacteriophage translocation. FEMS Immunol Med Microbiol. 2006;46:313–9.CrossRefPubMed
32.
go back to reference Weber-Dąbrowska B, Dąbrowski M, Ślopek S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch Immunol Ther Exp. 1987;35:563–8. Weber-Dąbrowska B, Dąbrowski M, Ślopek S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch Immunol Ther Exp. 1987;35:563–8.
33.
go back to reference Bruttin A, Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005;49:2874–8.CrossRefPubMedPubMedCentral Bruttin A, Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005;49:2874–8.CrossRefPubMedPubMedCentral
34.
go back to reference Górski A, Międzybrodzki R, Borysowski J, et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv Virus Res. 2012;83:41–71.CrossRefPubMed Górski A, Międzybrodzki R, Borysowski J, et al. Phage as a modulator of immune responses: practical implications for phage therapy. Adv Virus Res. 2012;83:41–71.CrossRefPubMed
35.
go back to reference Brown-Jaque M, Muniesa M, Navarro F. Bacteriophages in clinical samples can interfere with microbiological diagnostic tools. Sci Rep. 2016;6:33.CrossRef Brown-Jaque M, Muniesa M, Navarro F. Bacteriophages in clinical samples can interfere with microbiological diagnostic tools. Sci Rep. 2016;6:33.CrossRef
36.
go back to reference Thannesberger J, Hellinger HJ, Klymiuk I, et al. Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples. FASEB J. 2017;31:1987–2000.CrossRefPubMed Thannesberger J, Hellinger HJ, Klymiuk I, et al. Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples. FASEB J. 2017;31:1987–2000.CrossRefPubMed
37.
39.
go back to reference Barr JJ, Auro R, Sam-Soon N, et al. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters. PNAS. 2015;112:13675–80.CrossRefPubMedPubMedCentral Barr JJ, Auro R, Sam-Soon N, et al. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters. PNAS. 2015;112:13675–80.CrossRefPubMedPubMedCentral
40.
go back to reference Górski A, Dąbrowska K, Świtała-Jeleń K, et al. New insights into the possible role of bacteriophages in host defense and disease. Med Immunol. 2003;2:2–6.CrossRefPubMedPubMedCentral Górski A, Dąbrowska K, Świtała-Jeleń K, et al. New insights into the possible role of bacteriophages in host defense and disease. Med Immunol. 2003;2:2–6.CrossRefPubMedPubMedCentral
41.
42.
go back to reference Broecker F, Russo G, Klumpp J, Moelling K. Stable core virome despite variable microbiome after fecal transfer. Gut Microbes. 2017;8:214–20.CrossRefPubMed Broecker F, Russo G, Klumpp J, Moelling K. Stable core virome despite variable microbiome after fecal transfer. Gut Microbes. 2017;8:214–20.CrossRefPubMed
43.
go back to reference Ott SJ, Waetzig GH, Rehman A, et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology. 2017;152:799–811.CrossRefPubMed Ott SJ, Waetzig GH, Rehman A, et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology. 2017;152:799–811.CrossRefPubMed
Metadata
Title
Bacteriophages in the gastrointestinal tract and their implications
Authors
Marzanna Łusiak-Szelachowska
Beata Weber-Dąbrowska
Ewa Jończyk-Matysiak
Renata Wojciechowska
Andrzej Górski
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Gut Pathogens / Issue 1/2017
Electronic ISSN: 1757-4749
DOI
https://doi.org/10.1186/s13099-017-0196-7

Other articles of this Issue 1/2017

Gut Pathogens 1/2017 Go to the issue